OBJECTIVE: To investigate whether testosterone administration alters natriuretic peptide levels in women. DESIGN: Three-month, double-blind, randomized, placebo-controlled study. SETTING: Clinical research center. PATIENT(S): Fifty-one women with hypoandrogenemia due to hypopituitarism. INTERVENTION(S): Transdermal testosterone (300 μg daily) or placebo patch. MAIN OUTCOME MEASURE(S): N-Terminal pro-B-type natriuretic peptide (NT-proBNP) levels. RESULT(S): NT-proBNP levels decreased in the transdermal testosterone group compared with placebo over three months. The difference between groups remained significant after controlling for baseline age, systolic blood pressure, body mass index, and homeostasis model assessment of insulin resistance. Change in NT-proBNP over 3 months was inversely associated with change in free testosterone levels. CONCLUSION(S): Testosterone administration to women results in decreased natriuretic peptide levels, suggesting that testosterone may be an inverse regulator of the natriuretic peptide system. CLINICAL TRIALS REGISTRATION NUMBER: NCT00027430.
RCT Entities:
OBJECTIVE: To investigate whether testosterone administration alters natriuretic peptide levels in women. DESIGN: Three-month, double-blind, randomized, placebo-controlled study. SETTING: Clinical research center. PATIENT(S): Fifty-one women with hypoandrogenemia due to hypopituitarism. INTERVENTION(S): Transdermal testosterone (300 μg daily) or placebo patch. MAIN OUTCOME MEASURE(S): N-Terminal pro-B-type natriuretic peptide (NT-proBNP) levels. RESULT(S): NT-proBNP levels decreased in the transdermal testosterone group compared with placebo over three months. The difference between groups remained significant after controlling for baseline age, systolic blood pressure, body mass index, and homeostasis model assessment of insulin resistance. Change in NT-proBNP over 3 months was inversely associated with change in free testosterone levels. CONCLUSION(S): Testosterone administration to women results in decreased natriuretic peptide levels, suggesting that testosterone may be an inverse regulator of the natriuretic peptide system. CLINICAL TRIALS REGISTRATION NUMBER: NCT00027430.
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Eric P Leip; Emelia J Benjamin; Peter W F Wilson; Patrice Sutherland; Torbjorn Omland; Ramachandran S Vasan Journal: Am J Cardiol Date: 2002-08-01 Impact factor: 2.778
Authors: Michael G Fradley; Martin G Larson; Susan Cheng; Elizabeth McCabe; Erin Coglianese; Ravi V Shah; Daniel Levy; Ramachandran S Vasan; Thomas J Wang Journal: Am J Cardiol Date: 2011-08-23 Impact factor: 2.778
Authors: Carolyn S P Lam; Susan Cheng; Karen Choong; Martin G Larson; Joanne M Murabito; Christopher Newton-Cheh; Shalender Bhasin; Elizabeth L McCabe; Karen K Miller; Margaret M Redfield; Ramachandran S Vasan; Andrea D Coviello; Thomas J Wang Journal: J Am Coll Cardiol Date: 2011-08-02 Impact factor: 24.094
Authors: Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett Journal: J Am Coll Cardiol Date: 2002-09-04 Impact factor: 24.094
Authors: Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang Journal: Nat Genet Date: 2009-02-15 Impact factor: 38.330
Authors: Karen K Miller; William Rosner; Hang Lee; Joan Hier; Gemma Sesmilo; David Schoenfeld; Gregory Neubauer; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2004-02 Impact factor: 5.958
Authors: Navin Suthahar; Wouter C Meijers; Jennifer E Ho; Ron T Gansevoort; Adriaan A Voors; Peter van der Meer; Stephan J L Bakker; Stephane Heymans; Vanessa van Empel; Blanche Schroen; Pim van der Harst; Dirk J van Veldhuisen; Rudolf A de Boer Journal: Eur J Heart Fail Date: 2018-06-01 Impact factor: 15.534
Authors: Małgorzata Kałużna; Tomasz Krauze; Katarzyna Ziemnicka; Katarzyna Wachowiak-Ochmańska; Jolanta Kaczmarek; Adam Janicki; Andrzej Wykrętowicz; Marek Ruchała; Przemysław Guzik Journal: Endocrine Date: 2021-02-22 Impact factor: 3.633